Alcohol-Related DisordersPhase 2NCT00000261
Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
A Phase 2 study testing 30% Nitrous oxide, 0.2% sevoflurane and 0.4% sevoflurane in people with Alcohol-Related Disorders and Opioid-Related Disorders, run by University of Chicago at 1 site in United States.
Trial summary
The purpose of this study is to evaluate the effects of alcohol history on the subjective and reinforcing effects of sevoflurane and nitrous oxide in healthy volunteers. All subjects underwent psychomotor testing during 4 sessions of placebo, drug/placebo, and choice of intervention. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Alcohol-Related Disorders, Opioid-Related Disorders, Substance-Related Disorders
- What is being tested?
- 30% Nitrous oxide, 0.2% sevoflurane and 0.4% sevoflurane
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 14 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 1997to Oct 1998
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Please contact site for information.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, 60637
About this study
Official title: Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide
The purpose of this study is to evaluate the effects of alcohol history on the subjective and reinforcing effects of sevoflurane and nitrous oxide in healthy volunteers. All subjects underwent psychomotor testing during 4 sessions of placebo, drug/placebo, and choice of intervention.
- Being tested
- 30% Nitrous oxide, Placebo, 0.2% sevoflurane, 0.4% sevoflurane, 0.6% sevoflurane
- Keywords
- nitrous oxide, sevoflurane, ethanol, subjective effects, healthy volunteer
- Medical subject headings
- Alcohol-Related Disorders, Opioid-Related Disorders, Substance-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
30% Nitrous oxideDrug
PlaceboOther
No drug (100% oxygen)
0.2% sevofluraneDrug
0.4% sevofluraneDrug
0.6% sevofluraneDrug
| Study group | Role | What they receive |
|---|---|---|
| Moderate drinking adults | Experimental | Not described Receives: Drug: 30% Nitrous oxide; Other: Placebo; Drug: 0.2% sevoflurane; Drug: 0.4% sevoflurane; Drug: 0.6% sevoflurane |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mood
Measured: Baseline, inhalation, recovery
Psychomotor performance
Measured: Baseline, inhalation, recovery
Choice of drug vs placebo
Measured: After placebo and drug in each session
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 1999 (estimated)
- Study startNov 1997
- Primary completionOct 1998
- Study completionOct 1998
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alcohol-Related DisordersStudies of the same condition, open and under way.
- More trials run by University of ChicagoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 14 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Chicago
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Responsible party
- Sponsor
- Investigators
- James Zacny, Ph.D., Principal investigator, University of Chicago
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00000261
- Sponsor's protocol ID
- NIDA-08391-13
- Other IDs
- R01DA008391, R01-08391-13
- Status last verified
- May 2015
- First submitted
- 20 Sep 1999
- Last updated
- 27 May 2015
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 May 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide
- ClinicalTrials.gov ID
- NCT00000261
- Acronym / sponsor ID
- NIDA-08391-13
- Keywords
- nitrous oxide, sevoflurane, ethanol, subjective effects, healthy volunteer
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 14 participants (actual)
- Lead sponsor
- University of ChicagoUniversity, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Study start
- Nov 1997
- Primary completion
- Oct 1998 (actual)
- Study completion
- Oct 1998 (actual)
- First posted
- 21 Sep 1999 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the effects of alcohol history on the subjective and reinforcing effects of sevoflurane and nitrous oxide in healthy volunteers. All subjects underwent psychomotor testing during 4 sessions of placebo, drug/placebo, and choice of intervention.
Study design
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- Double blind (participant, care provider)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Moderate drinking adults | Experimental | Drug: 30% Nitrous oxide, Other: Placebo, Drug: 0.2% sevoflurane, Drug: 0.4% sevoflurane, Drug: 0.6% sevoflurane |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 30% Nitrous oxide | Drug | Moderate drinking adults |
| PlaceboNo drug (100% oxygen) | Other | Moderate drinking adults |
| 0.2% sevoflurane | Drug | Moderate drinking adults |
| 0.4% sevoflurane | Drug | Moderate drinking adults |
| 0.6% sevoflurane | Drug | Moderate drinking adults |
Primary outcome
Mood
Time frame: Baseline, inhalation, recovery
Psychomotor performance
Time frame: Baseline, inhalation, recovery
Choice of drug vs placebo
Time frame: After placebo and drug in each session
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 May 2015.
Related trials for Alcohol-Related Disorders
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
RecruitingPhase 1
Environment and Alcohol: A Pilot Study
Alcohol Use Disorder
Not yet recruiting
Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial
Acute-on-Chronic Liver Failure (ACLF)
RecruitingObservational study
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Alcoholism, Substance-Related Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
James Zacny, Ph.D. principal investigator
University of Chicago
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing 30% Nitrous oxide, 0.2% sevoflurane and 0.4% sevoflurane in people with Alcohol-Related Disorders and Opioid-Related Disorders, run by University of Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 May 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mood (time frame: Baseline, inhalation, recovery). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2015.